LLY

1,014.2

-2.5%↓

JNJ

203.5

-1.16%↓

ABBV

229.23

+0.8%↑

UNH

334.19

+0.48%↑

AZN

90.44

-0.75%↓

LLY

1,014.2

-2.5%↓

JNJ

203.5

-1.16%↓

ABBV

229.23

+0.8%↑

UNH

334.19

+0.48%↑

AZN

90.44

-0.75%↓

LLY

1,014.2

-2.5%↓

JNJ

203.5

-1.16%↓

ABBV

229.23

+0.8%↑

UNH

334.19

+0.48%↑

AZN

90.44

-0.75%↓

LLY

1,014.2

-2.5%↓

JNJ

203.5

-1.16%↓

ABBV

229.23

+0.8%↑

UNH

334.19

+0.48%↑

AZN

90.44

-0.75%↓

LLY

1,014.2

-2.5%↓

JNJ

203.5

-1.16%↓

ABBV

229.23

+0.8%↑

UNH

334.19

+0.48%↑

AZN

90.44

-0.75%↓

Home・Aktien・Madrigal Pharmaceuticals Inc

Madrigal Pharmaceuticals Inc

Open

BrancheGesundheitswesen

583.14 -0.47

Buy Sell

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

570.81

Max

592.54

Schlüsselkennzahlen
By Trading Economics
Einkommen	-72M -114M
Verkäufe	74M 287M
EPS	-4.956
Gewinnspanne	-39.75
Angestellte	528
EBITDA	-75M -114M

Empfehlungen
By TipRanks
Empfehlungen	Starkes Kaufsignal
12-Monats-Prognose	-1.99% downside

Marktstatistiken
By TradingEconomics
Marktkapitalisierung	4B 13B
Vorheriger Eröffnungskurs	583.61
Vorheriger Schlusskurs	583.14

Nachrichtenstimmung

By Acuity

23%

77%

49 / 374 Ranking in Healthcare

Technischer Score

By Trading Central

Vertrauen

Very Strong Bearish Evidence

263.2 / 277.1 Unterstützung & Widerstand

Madrigal Pharmaceuticals Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

3. Dez. 2025, 23:21 UTC

Ergebnisse

Akquisitionen, Fusionen, Übernahmen

EQB to Buy Loblaw Unit PC Financial for About $573.5 Million -- Update

3. Dez. 2025, 23:14 UTC

Akquisitionen, Fusionen, Übernahmen

EQB to Buy PC Financial From Loblaw for About $573.5 Million

3. Dez. 2025, 22:01 UTC

Wichtige Markttreiber

Costco Wholesale Reports Higher Monthly Sales

3. Dez. 2025, 21:38 UTC

Ergebnisse

Salesforce Raises Revenue Forecast as Agentforce Sales Top $500 Million

3. Dez. 2025, 23:59 UTC

Market Talk

Australian Coal Prices Seen Having Recovered Well -- Market Talk

3. Dez. 2025, 23:49 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

3. Dez. 2025, 23:49 UTC

Market Talk

HSBC Chair Appointment Unlikely to Have Material Operational Impact -- Market Talk

3. Dez. 2025, 23:49 UTC

Market Talk

Nikkei May Decline Amid Caution Over U.S. Labor Market -- Market Talk

3. Dez. 2025, 23:13 UTC

Market Talk

Australian Treasurer Says Economy Not On Drip of Govt Spending -- Market Talk

3. Dez. 2025, 23:10 UTC

Ergebnisse

Salesforce Raises Forecast as Agentforce Sales Top $500M -- Update

3. Dez. 2025, 23:08 UTC

Market Talk

Goodman's New Bull Sees Profit Upgrade on Cards -- Market Talk

3. Dez. 2025, 23:06 UTC

Akquisitionen, Fusionen, Übernahmen

EQB to Buy Loblaw Unit PC Financial for About $573.5M -- Update

3. Dez. 2025, 22:59 UTC

Akquisitionen, Fusionen, Übernahmen

EQB to Buy PC Financial From Loblaw for About $573.5M

3. Dez. 2025, 22:45 UTC

Market Talk

WiseTech Investor Day Increases Bull's Confidence -- Market Talk

3. Dez. 2025, 22:20 UTC

Ergebnisse

Salesforce CEO: 9,500 of 18,500 Total Closed Agentforce Deals Are Paid

3. Dez. 2025, 22:19 UTC

Ergebnisse

Salesforce CEO: Six Out of 10 Biggest Deals in 3Q Came from Agentforce

3. Dez. 2025, 22:17 UTC

Ergebnisse

Salesforce Working to Add Voice to Agentforce, CEO Says

3. Dez. 2025, 22:16 UTC

Ergebnisse

Salesforce CEO: Williams-Sonoma's Agentforce Makes Up 60% of Customer Chats

3. Dez. 2025, 22:15 UTC

Ergebnisse

Salesforce CEO: Agentforce ARR Was $540M in 3Q

3. Dez. 2025, 22:10 UTC

Akquisitionen, Fusionen, Übernahmen

EQB: Will Enter Into a Long-Term Strategic Relationship With Loblaw >EQB.T

3. Dez. 2025, 22:09 UTC

Akquisitionen, Fusionen, Übernahmen

EQB: Agreed to Acquire PC Fincl From Loblaw >EQB.T

3. Dez. 2025, 21:50 UTC

Market Talk

Auto & Transport Roundup: Market Talk

3. Dez. 2025, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

3. Dez. 2025, 21:49 UTC

Ergebnisse

Salesforce Reports Mounting Profits. The Stock Is Rising. -- Barrons.com

3. Dez. 2025, 21:23 UTC

Ergebnisse

Salesforce Raises Revenue Forecast as Agentforce Sales Top $500M

3. Dez. 2025, 21:19 UTC

Ergebnisse

Salesforce Reports Mounting Profits. The Stock Is Rising. -- Barrons.com

3. Dez. 2025, 21:06 UTC

Ergebnisse

Salesforce Reports Mixed Earnings. The Stock Is Rising. -- Barrons.com

3. Dez. 2025, 21:04 UTC

Ergebnisse

Salesforce Sees Profitable Growth Framework Target of 50 by FY30 >CRM

3. Dez. 2025, 21:04 UTC

Ergebnisse

Salesforce Targets $60 B Plus Organic Rev by FY30 >CRM

3. Dez. 2025, 21:03 UTC

Ergebnisse

Salesforce Raises FY26 Oper Cash Flow Growth Guidance to 13% to 14% Y/Y >CRM

Peer-Vergleich

Kursveränderung

Madrigal Pharmaceuticals Inc Prognose

Kursziel

By TipRanks

-1.99% Nachteil

12-Monats-Prognose

Durchschnitt 561.73 USD -1.99%

Hoch 650 USD

Tief 445 USD

Basierend auf 12 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Madrigal Pharmaceuticals Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Starkes Kaufsignal

12 ratings

Buy

Halten

Sell

Basierend auf 12 Analysten, die in den letzten 3 Monaten Aktienbewertungen für Madrigal Pharmaceuticals Inc – Dist abgegeben haben.

Technischer Score

By Trading Central

263.2 / 277.1Unterstützung & Widerstand

Bearish events outweigh bullish events.

Recent bearish events outweigh bullish events.

The bullish and bearish events are balanced.

Stimmung

By Acuity

49 / 374 Ranking in Gesundheitswesen

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

Über Madrigal Pharmaceuticals Inc

Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of non-alcoholic steatohepatitis (NASH) in the United States. Its lead product candidate is resmetirom, a liver-directed thyroid hormone receptor beta agonist, which is in Phase 3 clinical trials for treating NASH. The company is headquartered in West Conshohocken, Pennsylvania.